abstract: Human small antral follicles (diameter 3-9 mm) were obtained from ovaries surgically removed for fertility preservation.
Introduction
During folliculogenesis androgens serve an important function as substrate for granulosa cell estradiol synthesis, and perform, in addition, a number of trophic functions during follicular growth, especially in earlier developmental stages prior to follicular selection. Studies in rhesus monkeys almost a decade ago showed that androgens, administered in pellets that provide slow release for 3-10 days, stimulate growth in follicles until the early antral stage (Vendola et al., , 1999a . Proliferation of granulosa cells was significantly increased and the number of growing follicles augmented after exposure to testosterone or dihydrotestosterone treatment (Vendola et al., , 1999a . Furthermore, androgen receptor (AR) gene expression in granulosa cells from these primate ovaries, evaluated by in situ hybridazation, correlated positively with proliferation and negatively with apoptosis .
Subsequent studies demonstrated interactions between FSH and androgens in the follicular development and revealed that follicles demonstrate a highly significant positive correlation between the FSH receptor (FSHR) and AR mRNA levels when comparing the mean expression from each group of follicles in each individual monkey (Weil et al., 1999) . Furthermore, testosterone administration that resulted in supra-physiological levels augmented granulosa cell FSHR expression and it was suggested that androgens promote follicular growth by sensitizing granulosa cells to FSH action (Weil et al., 1999) .
In the ovary, the AR seemed predominantly to be expressed by the granulosa cells and in particular by the smaller follicles (rats: Harlow et al., 1986; Tetsuka and Hillier, 1997; marmoset: Hillier et al., 1997) . However, in humans and sheep, the pattern of AR expression in granulosa cells appears to be regulated differently from that in rat and monkey, since granulosa cell AR immunostaining was reported to be stronger in pre-ovulatory follicles than in smaller follicles (human: Horie et al., 1992 , sheep: Campo et al., 1985 . A recent study in mouse that used granulosa cells and oocyte-specific AR knockout mice found that such mice had premature ovarian failure and were subfertile, with longer oestrous cycles and fewer ovulated oocytes (Sen and Hammes, 2010) . It was concluded that the AR appears to promote pre-antral follicle growth and prevent follicular atresia and are essential for normal follicular development and fertility (Sen and Hammes, 2010) .
At the clinical level, the above observations may explain the response women with hyper-androgenism often show when treated with exogenous FSH administration for ovulation induction. These women may react with an exaggerated follicular response, suggesting that their granulosa cells are especially sensitive to FSH stimulation (Farhi and Jacobs, 1997 ; Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2008) . Indeed, a number of studies have shown that granulosa cells from PCOS women during culture are hyper-responsive to FSH and possess an augmented capacity for synthesizing estrogens (Mason et al., 1994) . In a group of women who showed a moderate or poor response to ovarian stimulation with exogenous gonadotrophins the use of locally produced androgens to augment sensitivity to FSH stimulation and to increase the number of retrieved mature oocytes has recently been attempted (Løssl et al., 2006) . Prior to controlled ovarian stimulation with exogenous gonadotrophins local ovarian androgen production was enhanced by pre-treating women with a bolus of hCG, thereby stimulating local androgen production and by co-administering an aromatase inhibitor to prevent the conversion of androgens to estrogens (Løssl et al., 2006) . Compared with a control group the androgen pretreatment group developed significantly more embryos following ovarian stimulation and IVF treatment, supporting the concept that androgens may also enhance follicular responsiveness and FSHR expression in humans. However, since the AR appears to be mainly expressed in pre-ovulatory follicles in women (Horie et al., 1992) , it is unclear at what developmental stage FSH sensitivity is enhanced and whether it is feasible to augment follicular responsiveness to smaller follicles.
Human small antral follicles are scarce material and not many studies have been performed on such individual small follicles. In the present study, we took advantage of the presence of normal small antral follicles in ovaries surgically removed for fertility preservation by cryopreservation of the ovarian cortex. The antral follicles located in the medually part cannot sustain freezing and are normally discarded in this procedure. In order to characterize human antral follicles and evaluate whether AR expression played similar roles in humans as found in primates and other species, the aim of the present study was to determine AR mRNA expression in granulosa cells of normal small human antral follicles and to correlate that with the mRNA expression of FSHR, LH receptor (LHR), AMH receptor II (AMHRII) and aromatase (CYP19). In addition, the hormonal characteristics of the corresponding follicular fluid were also evaluated.
Materials and Methods
Patients and collection of small antral follicular fluid Granulosa cell and follicular fluid samples were obtained from individual small antral follicles present in ovaries surgically removed for fertility preservation. Cryopreservation of the ovarian cortex was offered as means of fertility preservation to patients in whom the appropriate treatment posed a high risk of eliminating the ovarian follicle pool.
A total of 64 follicles were obtained from 24 women aged 15 -37 years (median 29 years) at various times during their menstrual cycle. Diagnosis for ovarian cryopreservation included mammary cancer (9), Hodgkin's and non-Hodgkin's disease (5), Ewing and oestogenic sarcoma (3), lymphoma (2), rectum cancer (1), cervical cancer (2), medulla blastoma (1) and dermatomyositis (1). None of the women received GnRH agonists and two women received oral contraception. All ovaries appeared normal by (i) visual inspection in connection with the cryopreservation procedure and (ii) by subsequent microscopic evaluation of histological sections from a small piece of the ovarian cortex.
The follicles were collected immediately after recovery of the ovary prior to, or during, isolation of the ovarian cortex. Each antral follicle visible on the surface of the ovary or observed during preparation of cortex was aspirated with a 1 ml syringe with a 26-gauge needle (Becton Dickinson, Brøndby, Denmark). The granulosa cells of each small follicle were isolated from the follicular fluid by centrifugation (2000g, 2 min). After aspirating the follicular fluid from the granulosa cells in the pellet, each ampoule of granulosa cells and follicular fluid were snap-frozen in liquid nitrogen and stored at -808C until RNA purification or until measurement of hormones.
One to eight antral follicles were collected per patient (one follicular fluid, five patients; two follicular fluids, eight patients; three follicular fluids, seven patients; four follicular fluids, two patients; six follicular fluids, one patient; eight follicular fluids, one patient). The volume of each follicle was estimated from the volume in the syringe and only those with a volume from 30 to 350 ml corresponding to 3 -9 mM in diameter were included in the study. The ethical committee of the municipalities of Copenhagen and Frederiksberg approved the project. Results from this material have been used in a previous publication (Nielsen et al., 2010) .
RNA purification
Total RNA was purified under RNase-free conditions at room temperature using Tri Reagent (Sigma-Aldrich, St Louis, MO, USA) in combination with the RNAeasy Mini Kit (Qiagen, Hilden, Germany). Each cell sample was lysed in 1 ml Tri Reagent according to the Tri Reagent protocol and incubated at room temperature for 5 min. Following addition of 200 ml 1-bromo-3-chloropropane (Sigma-Aldrich), the cell sample solutions were shaken vigorously for 15 s and incubated at room temperature for 5 min. Following centrifugation at 15 000g for 15 min at 48C, the mixture separated into three phases and the upper aqueous phase containing the RNA was transferred to a clean, RNase-free Eppendorf tube. The following steps of RNA purification was carried out according to the RNeasy Mini Kit protocol. The final elution step was repeated and the purified total RNA was subsequently stored at 2608C.
The samples were analysed for total RNA quality and level of degradation using an Agilent 2100 Bioanalyzer and RNA 6000 Pico LabChip according to the manufacturer's instructions (RNA 6000 Pico assay kit, Agilent Technologies, Waldbronn, Germany). RNA samples which did not show two peaks representing 18 and 28 s rRNA were excluded. Total RNA quantity was evaluated using the Nanodrop w ND1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA).
DNA synthesis and RT-PCR analysis
First-strand cDNA was synthesized using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer's manual. A master mix containing 2.0 ml 10× RT Buffer, 0.8 ml 25× dNTP Mix (100 mM), 2.0 ml of 10× RT random primers, 1.0 ml of MultiScribe TM Reverse Transcriptase (50 U/ml), 1.0 ml of RNase Inhibitor and 3.2 ml of nuclease-free (Diethylpyrocarbonate, DEPC) water was prepared and for each 20 ml of reaction 10 ml of master mixture was added to an equal volume of total RNA (concentrations ranging from 5 to 10 ng/ml). All steps were performed on ice. Samples were centrifuged briefly at 12 000g and then incubated at room temperature for 10 min, followed by 378C for 2 h and finally, the reaction was stopped at 858C for 5 s. First-strand cDNA was stored at 2208C until real-time PCR analysis.
Evaluation of gene expression levels was achieved by relative quantification (RQ) real-time PCR analysis using TaqMan w technology (Applied Biosystems). FSHR, LHR, CYP19a1 and AMH-r2 TaqMan w Gene Expression Assays (pre-designed) as well as the Endogenous Control Assays for human b-actin and glyceraldehyde 3-phosphatdehydrogenase (GAPDH) were purchased from Applied Biosystems (Assay id-no.: b-actin:#4326315E; GAPDH:#4333764F; AR:#Hs00171172_m1 FSHR:# Hs00174865_m1; LHR:#Hs00174885_m1; AMHRII:#Hs00179718_m1; CYP19a1:#Hs00903413_m1). Sample triplicates were prepared according to the manufacturer's instructions. A total reaction volume of 25 ml was prepared on ice containing 12.5 ml TaqMan w Universal PCR Master Mix, No AmpErase w UNG(2X), 1.25 ml 20X TaqMan w Gene Expression Assay Mix, 1.7-1.85 ml undiluted cDNA and RNase-free water up to 25 ml. The samples were then centrifuged at 2800g at 48C for 5 min.
cDNA was amplified using the 7500 Real-time PCR system (Applied Biosystems) under the following thermal cycling conditions: 958C for 10 min, 45 cycles of 958C for 15 s and 608C for 1 min. The data were subsequently analysed using human b-actin and GAPDH as housekeeping genes and the SDS Software for Relative Quantification (Applied Biosystems). The calculation of the expression levels of each individual gene was carried out according to the Comparative C T Method for RQ as described by the manufacturer (Relative Quantification of Gene Expression: User Bulletin #2, Applied Biosystems). The expression levels were related to the housekeeping genes human b-actin and GAPDH. The expression level for each gene was calculated according to human b-actin and GAPDH separately, and the DDC T values were compared. If no deviation was observed, the housekeeping gene expression was considered to be constant. As another test for variation in housekeeping gene expression, the ratios between the RQ values for the five target genes calculated according to b-actin or GAPDH, were compared. On the basis of these two tests, the housekeeping genes were considered to remain sufficient constantly expressed. Often, expression levels are expressed as 2 −DDCT when compared with the expression of a calibrator or another target gene. Normalized expression levels can also be expressed as 2 −DDCT , for example, when expression levels are not related to a calibrator. The expression levels in this study are therefore presented as 2 −DCT and normalized to GAPDH (Applied Biosystems Support; Schmittgen and Livak, 2008) .
Hormone measurements
Estradiol and progesterone were measured using commercially available RIA kits (DSL-43100 & DSL-3400; Diagnostic System Laboratories, Webster, TX, USA). Samples for both assays were diluted 1:50 in steroidfree serum just prior to measurement. Androstenedione was measured using an RIA kit (DSL-3800) with samples being diluted 1:200 in steroidfree serum and testosterone using an RIA kit (DSL-4000) diluted 1:100 in steroid-free serum.
The steroid-free serum was produced in-house by stripping a pool of serum with repeated washings of charcoal particles. The charcoal was removed through several filtering steps ending with a sterile filter to ensure total removal of charcoal particles. Blank samples were tested for the absence of steroids prior to the running hormone assays.
AMH was measured using a specific ELISA-kit according to the manufacturer's instructions (DSL-10-14400; Diagnostic System Laboratories). Follicular fluid samples from small antral follicles were diluted either 1:500 or 1:3000 in the zero standard provided by the manufacturer. Inter-assay variation of a sample containing 7.6 ng AMH/ml was 4.4 % (n ¼ 12) and intra-assay variation was 3.3% (n ¼ 5) of sample containing 0.45 ng/ml. Dilution curves of follicular fluid samples proved parallel to the standard curve.
Inhibin-B was measured using a specific ELISA-kit according the manufacturer's instructions (The Oxford Bio-innovation kit; Biotech-IgG, Copenhagen, Denmark). Prior to measurement, all follicular fluid samples irrespective of whether they derived from small antral or preovulatory follicles were diluted 1:100 or 1:500 in serum obtained from a pool of five post-menopausal women (who had no inhibin-B activity). The follicular fluids were pre-treated with SDS, heated, and exposed to hydrogen peroxide before they were applied to the wells of the plate and incubated overnight at room temperature. Subsequently, the plates were washed and incubated with detection antibody for 3 h at room temperature. Substrate solution was applied and incubated for 1 h. The amplifier solution was added, and the plates were read at 490 nm with an ELISA reader with its reference at 620 nm (coefficient of variation ,7%).
SDS -polyacrylamide gel electrophoresis and western blot analysis
Cell lysates were prepared by using 0.5% sulphSDS lysis buffer. Lysates were sonicated and centrifuged at 20 000g to precipitate debris. Protein concentrations were compared with a BCA protein standard (Pierce Biotechnology, Rockford, IL, USA) and measured with a ' Protein assay (BioRAD Laboratories, CA, USA, DC based on Lowry's method) ensuring that equal amounts of protein could be loaded in each lane. Proteins were analysed by SDS -polyacrylamide gel electrophoresis (PAGE) and western blot analysis using the XCell and XCell II blot module systems (Novex) as described (Christensen et al., 2001) . Briefly, proteins were separated by gel electrophoresis under denaturing and reducing conditions on 10% NuPAGE Bis -Tris gels (NP0303BOX, Invitrogen, Taastrup, Denmark) using NuPAGE MOPS SDS running buffer (NP0001, Invitrogen) and Fermentas protein standards. Separated proteins were electrophoretically transferred to nitrocellulose membranes (LC2000, Invitrogen), which were stained in 1% Ponceau S red solution (P7170, Sigma-Aldrich, Copenhagen, Denmark), and incubated for 1 h at room temperature in blocking buffer [5% non-fat dry milk in TBST (0.01 M Tris-HCl, 0.15 M NaCl, 0.1% Tween 20, pH 7.4)] before incubation with primary antibodies in blocking buffer overnight at 48C. The antibodies used were rabbit polyclonal anti-AR (N-20) (1:200; Santa Cruz Biotechnology, CA, USA), rabbit polyclonal anti-AR (N-20) blocking peptide (40:1; Santa Cruz Biotechnology) and mouse monoclonal anti-b-actin (1:5000; Sigma-Aldrich). The membranes were washed several times in TBST, incubated for 1 h with alkaline phosphatase-coupled secondary antibodies diluted 1:5000 in blocking buffer, and washed in TBST prior to development with S-bromo-D-chloro-3-indolyl phosphate/nitro blue tetrazolium solution (KLP, Gaithersburg, MD, USA). The developed blots were scanned and processed for publication in Adobe Photoshop version 6.
Immunohistochemistry
For immunohistochemistry ovarian medulla tissue containing an antral follicle was dissected free and fixed in Bouin's fixative. The tissue was prepared for histology. Five micrometre paraffin sections were dewaxed, rehydrated and washed in TBS (0.05 M Tris, pH 7.6, 0.15 M NaCl) with 0.01% Nonidet P-40 (TBS/Nonidet). Sections were incubated in 0.45% H 2 O 2 in TBS/Nonidet for 15 min to block endogenous peroxidase activity, and then in 10% normal goat serum in TBS/Nonidet for 30 min at room temperature to block non-specific binding. All sections were incubated overnight at 48C with the primary antibody raised against the human AR (#SC-816, Santa Cruz Biotechnology) diluted 1:50 in 10% goat serum. The primary antibody was detected using DakoCytomation EnVision+ DualLink System, Peroxidase (DAB+) code K4065, following the manufacturer's instructions. As a negative control, sections were incubated with Rabbit IgG (X0903 DakoCytomation) instead of the primary antibody. As a positive control, sections from fetal testes tissues with known occurrence of the antigen were used.
Statistics
For evaluation of a possible association between the levels of the measured substances, normal random effects models were used with a random effect of women to take into account that results from the same women may be more similar than results from different women. AR mRNA expression was grouped into four approximately equally sized groups (,20, 20 -45, .45 -130, .130 ) and similarly testosterone concentration was grouped (,45, 45 -210, .210 -350 , .350 nmol/l). The outcomes were log-transformed to approximate normality leading to geometric means being calculated in each group on the original scale. Likelihood ratio tests were conducted for equality over groups as well as trend tests. P-value of ,0.05 was accepted as statistical significance.
Results
The quality of the extracted total RNA allowed evaluation of the analysed genes in 55 of the 64 samples. In the remaining nine samples the concentration of the extracted total RNA was too low or not of appropriate quality for quantification of the gene expression levels. Table I shows the mRNA expression levels of AR divided into four groups of approximately equal size in relation to mRNA expression of FSHR, LHR, CYP19 (aromatase) and AMHRII expression. AR mRNA expression was highly significantly associated with the FSHR expression (Table II) . A significant linear trend was shown between the mRNA expression of AR and FSHR (P , 0.0001; Fig. 1 ). In addition, AMHRII mRNA expression was also significantly associated with the AR mRNA expression (Fig. 1) . In contrast, LHR and CYP19 mRNA expression did not show any significant associations with AR mRNA expression ( Table I) .
The correlation between mRNA levels of AR in granulosa cells and the corresponding follicular fluid levels of hormones showed no significant associations (Table II) The diameter of the majority of the follicles was present in a relative narrow range of around 4-7 mm (estimated from the aspirated volume) and the AR mRNA expression did not show any significant correlation to the follicular volume (data not shown). Table III shows the follicular fluid concentrations of testosterone divided into four groups of approximately equal size in relation to the mRNA expression of FSHR, LHR, CYP19 (aromatase) and AMHRII expression. Intrafollicular concentrations of testosterone were highly significantly associated with FSHR mRNA expression in the corresponding granulosa cells, whereas LHR, CYP19 (aromatase) and AMHRII expression showed no significant associations. As expected, follicular fluid concentrations of testosterone showed a highly significant association with androstenedione, but no significant correlation to levels of inhibin-B.
Intrafollicular concentrations of androstenedione did not show significant correlations to mRNA expression levels for any of the evaluated substances except for the FSHR mRNA expression, which proved to be significant (P , 0.05; data not shown).
In patients in whom granulosa cells from more than one follicle were included, the FSHR mRNA levels were mostly seen to vary as much as between patients (Fig. 2) . Within patient variation reached one order of magnitude with the remaining variability being related to between patient variation (Fig. 2) . The other granulosa cell measured mRNAs showed a range similar to that of FSHR. Figure 3 shows a representative result of western blots of granulosa cells from small human antral follicles and demonstrated that the AR protein itself was expressed. A similar result was obtained with multiple samples. Expression levels of AR were higher in granulosa cells from antral follicles than in medulla tissue from human ovaries. As a control an extract from undifferentiated human embryonic stem cells showed no expression. The western blot result is supported by immunohistochemical staining of histological sections of a human antral follicle, which showed expression of the AR protein mainly on the granulosa cells but also some staining on the theca cells.
Discussion
The present study comprises material from human antral follicles with diameters from 3 to 9 mm obtained from normal ovaries. The data showed that granulosa cell FSHR gene expression was significantly associated with the expression of AR on the granulosa cells, and, in addition, significantly associated with the intrafollicular concentrations of androgens (i.e. androstenedione and testosterone). This suggests that the collective effect of androgens acting through the AR appears to promote gonadotrophins-responsiveness of developing human follicles. Although the present results should be interpreted with caution due to their correlative nature, they are in accordance with a number of previous studies on primates and rodents. Further, ovaries from rhesus monkeys showed that the AR gene was most abundantly expressed on granulosa cells in the ovary and augmented in healthy follicles. It was suggested that androgens stimulate early primate follicle development . Subsequent Androgen receptor and FSHR in human follicles studies found that exogenously administered androgens promote FSHR expression in vivo explaining earlier studies on the androgeninduced enhanced estrogen biosynthesis and partly explained the amplifying effect that androgens exert on FSH action (Weil et al., 1999) . Finally, a recent study on conditional granulosa cells and oocyte-specific AR knockout mice saw that increasing androgen and AR gene expression by small follicles was associated with increased FSHR expression, which adds to the perception that androgens via their receptors may stimulate pre-antral follicle growth, prevent atresia and are essential for normal follicular development (Sen and Hammes, 2010) . Taken together, the present results confirm and extends previous studies and suggest that androgens also in humans exert important functions in small antral follicles and indicate that proper androgen priming of such follicles enhance FSHR expression and make them more sensitive to FSH stimulation and subsequent growth.
Previous studies have shown that androgens enhance granulosa cells expression of FSHR in vitro resulting in an increased aromatase expression and an augmented conversion of androgen to estrogen (rat: De Zwart, 1981, 1982; Daniel and Armstrong, 1984; primate: Harlow et al., 1986) . However, in rhesus monkeys treated with large doses of exogenous androgens, testosterone was without effect on granulosa cell expression of aromatase and circulating levels of estradiol became reduced (Weil et al., 1999) . The present study of naive follicles support the in vivo data, since we were also unable to show an association between neither AR gene expression and aromatase expression, nor between follicular fluid androgens and aromatase expression. The fact that androgens and AR gene expression appear to promote FSHR expression in human follicles adds another regulatory element to the complex 2-cell two gonadotrophins regulation of follicular estradiol synthesis, but does suggest that proper FSH stimulation is a prerequisite for the androgen action to be effective. It is unlikely that the AR directly regulates the FSHR gene since no androgen response element on the FSHR gene promoter has been identified. It may be that the AR or follicular fluid androgens influence FSHR mRNA stability or may work indirectly, perhaps by causing enhanced local production of IGF1 or inhibin-B (Vendola et al., 1999a) . The significant association between the expression of AR and FSHR with AMHRII in the present study showed that the AMH signalling system also might affect the interaction between AR and FSHR expression.
Studies in post-pubertal gilts treated with dihydrotestosterone demonstrated a dose-dependant increase in ovulation rate (Cárdenas et al., 2002) . The androgen treatment resulted in an increased amount of FSHR mRNA in pre-ovulatory follicles and it was suggested that the androgen effect might be caused by an up-regulation of FSHR expression (Cárdenas et al., 2002) . Although an increased number of pre-ovulatory follicles were not reported in primate studies , the results of the present study suggest an increased FSH responsiveness of follicles that have a high expression of AR and contain high concentrations of androgen. Collectively, these results encourage pursuing clinical studies to evaluate whether androgen priming of patients who show a poor or inadequate follicular response following controlled ovarian stimulation can enhance follicular responsiveness and the number of recruitable follicles.
In fact several studies described administration of dehydroepiandrosterone (DHEA) to patients in order to increase the systemic levels of androgens and reported an enhanced harvest of mature oocytes subsequent to ovarian stimulation Gleicher, 2005, 2006; Sö nmezer et al., 2009) . Whether androgens augmented systematically by administration of DHEA or increased locally by stimulating the ovaries own androgen production (i.e. LH or hCG stimulation possible in combination with aromatase inhibitors that block the conversion of androgen to estrogen), it appears to make follicles more sensitive to FSH. To what extent an enhanced FSH responsiveness of follicles augment the quality of the enclosed oocyte and subsequently results in more fit embryos with a higher implantation potential is not yet clear. Further studies are needed to define the conditions by which androgen priming may improve clinical results, but the present study does encourage this approach.
It is further of interest that mRNA expression of AMHRII also was significantly associated with AR mRNA expression. In a previous study we found that FSHR was significantly associated with AMHRII mRNA expression (Nielsen et al., 2010) . The present study is unable to address whether AR and androgens affect AMHRII expression or whether it occurs via the FSHR or a different signal transduction pathway, but it does demonstrate that AMH, which occurs in concentrations of several hundreds ng/ml (Yding Andersen et al., 2008) , and its receptor AMHRII are likely to be involved in the complicated regulation of follicular growth and development.
This study was unable to demonstrate significant correlations between the follicular diameter and the AR mRNA expression. This may relate to the fact that the diameters of a majority of the follicles included had a relatively narrow range of 4-7 mm. In addition, the procedure by which the follicular fluid was aspirated may not have yielded the total volume of each individual follicle fluid in all cases. Further, the health status of the follicle may be expected to influence the results. In order to compensate for these shortcomings future studies should increase numbers in combination with assessment of the follicular health status.
In conclusion, using fluid and granulosa cells from normal human follicles with a diameter of 3-9 mm, the present study found a highly significant association between the expression of AR on granulosa cells, and the expression of FSHR, and between the follicular fluid content of androgens and FSHR expression. These results encourage further studies to improve results of already-employed strategies to enhance the outcome of ovarian stimulation by performing androgen priming prior to the administration of exogenous gonadotrophins.
